September 6, 2018 / Modified sep 6, 2018 5:10 p.m.

Grant Funds Research to Fight Deadly Lung Disease

The University of Arizona College of Medicine seeks a cure for excessive scar tissue.

Louise Hecker lab hands Scientists conduct research in the lab of Louise Hecker, an associate professor of medicine at the University of Arizona.
UAHS Communications

Louise Hecker, an associate professor of medicine at the University of Arizona, is conducting research that could save lives.

Idiopathic pulmonary fibrosis — excessive scar tissue in the lungs from an unknown source — affects mostly men over 60 years old, and there is no cure for the disease.

"One thing that people may not realize about scar tissue, and are surprised about, is that actually 45 percent of deaths each year in this country are scar-tissue related," Hecker said.

"And the reason that it's not a commonly known statistic is because people ultimately die of organ failure, but organ failure in many of these cases, like heart failure and liver cirrhosis, is caused by progressive fibrosis."

Louise Hecker Lab Researchers Louise Hecker, standing in middle, received a $4.4 million grant to study drugs that could halt or reduce excessive scar tissue.
UAHS Communications

Hecker and a team of other scientists are using the $4.4 million grant from the Department of Defense to test drugs that might eventually be able to stop or even reverse the excessive scar-tissue growth.

"So what we are able to do with this DOD grant is to take these drug candidates that we've identified and develop them all the way through large-animal toxicology, which are FDA requirements, to get these treatments to patients," she said.

The research could take several years before humans might be able to benefit from the drugs, but Hecker said the implications are pivotal.

"If we can find ways to stop and reverse progressive scar tissue in these internal organs then we'll be finding a way to live longer, healthier."

Louise Hecker Lab Louise Hecker, right, and other scientists are conducting research to battle excessive scar tissue in lungs, known as idiopathic pulmonary fibrosis.
UAHS Communications
By posting comments, you agree to our
AZPM encourages comments, but comments that contain profanity, unrelated information, threats, libel, defamatory statements, obscenities, pornography or that violate the law are not allowed. Comments that promote commercial products or services are not allowed. Comments in violation of this policy will be removed. Continued posting of comments that violate this policy will result in the commenter being banned from the site.

By submitting your comments, you hereby give AZPM the right to post your comments and potentially use them in any other form of media operated by this institution.
AZPM is a service of the University of Arizona and our broadcast stations are licensed to the Arizona Board of Regents who hold the trademarks for Arizona Public Media and AZPM. We respectfully acknowledge the University of Arizona is on the land and territories of Indigenous peoples.
The University of Arizona